Antimitotic Agents: all 5,052 studies that test it
Page 42 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLCTerminatedNCT00291850Phase 2
- Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric CancerCompletedNCT00290966Phase 2/3
- Maintenance Chemotherapy in Metastatic Breast CancerStatus unknownNCT00289263Phase 3
- Interaction of Docetaxel and Lonafarnib in Patients With Advanced CancerTerminatedNCT00288444Phase 1
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast CancerCompletedNCT00288249Phase 2
- Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic MelanomaCompletedNCT00288041Phase 2
- Topotecan and Vinorelbine in Treating Patients With Recurrent Lung CancerCompletedNCT00287963Phase 1
- Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid TumorsCompletedNCT00287937Phase 1
- Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic CancerCompletedNCT00287885Phase 1
- Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric CancerCompletedNCT00287768Phase 3
- A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic IrradiationTerminatedNCT00285415Phase 2
- Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate CancerCompletedNCT00284752Phase 2
- Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By SurgeryCompletedNCT00281970Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerCompletedNCT00281788Phase 1
- Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With PegfilgrastimCompletedNCT00280787Phase 2
- Docetaxel in the Treatment of Hormone Refractory Prostate CancerCompletedNCT00280098Phase 4
- Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00278460Phase 2
- Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00278421Phase 3
- Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgerySuspendedNCT00278122Phase 2
- Metronomic Oral Vinorelbine in Patients With Metastatic TumorsCompletedNCT00278070Phase 2
- Study Evaluating MST-997 in Advanced Malignant Solid TumorsTerminatedNCT00277836Phase 1
- Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast CancerCompletedNCT00277069Phase 1/2
- A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With TaxanesCompletedNCT00277043Phase 3
- A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid TumorsCompletedNCT00276913Phase 1
- Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT00276796Phase 2
- Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone SurgeryStatus unknownNCT00276666Phase 2
- Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade GliomasCompletedNCT00276640Not applicable
- Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00276588Phase 2
- Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue SarcomaCompletedNCT00276055Phase 1
- Radiation Therapy Followed By Combination Chemotherapy in Treating Young Patients With Supratentorial Primitive Neuroectodermal TumorsStatus unknownNCT00274911Phase 2
- An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With CarboplatinCompletedNCT00274443Phase 2
- Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck CancerCompletedNCT00273546Phase 3
- Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3TerminatedNCT00273507Phase 3
- DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])TerminatedNCT00273338Phase 3
- Patupilone Activity in Advanced/Metastatic Hepatocellular CarcinomaCompletedNCT00273312Phase 2
- Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC PatientsTerminatedNCT00271323Phase 2
- Efficacy Study of GEMOX Combination and Vinorelbine in NSCL PatientsCompletedNCT00271271Phase 2
- A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung CancerStatus unknownNCT00270582Phase 2
- An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric CancerStatus unknownNCT00270543Phase 2
- Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer.CompletedNCT00270491Phase 2
- A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.TerminatedNCT00269828Phase 3
- Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer PatientsCompletedNCT00268918Phase 1
- The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary CancerCompletedNCT00268840Phase 2
- Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC]CompletedNCT00268710Phase 2
- Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN)CompletedNCT00268671Phase 1/2
- Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate CancerCompletedNCT00268593Phase 2
- Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug EfficacyActive, not recruitingNCT00268476Phase 2/3
- S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the OropharynxTerminatedNCT00268372Phase 3
- Random Trial for Elderly Patients With NSCLCStatus unknownNCT00265694Phase 3
- HD11 for Intermediate StagesCompletedNCT00264953Phase 3
- Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung CancerTerminatedNCT00264134Phase 1/2
- Docetaxel in Non Small Cell Lung Cancer (NSCLC)TerminatedNCT00263016Phase 2
- Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal CancerCompletedNCT00262990Phase 3
- Study of Oxaliplatin and Taxotere in Prostate CancerCompletedNCT00260611Phase 2
- Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung CancerCompletedNCT00260026Phase 2
- Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLCCompletedNCT00259675Phase 2
- Docetaxel in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00258739Phase 2
- OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast CancerCompletedNCT00258375Phase 2
- Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate CancerCompletedNCT00258284Phase 2
- Capecitabine and Docetaxel in Advanced/Recurrent Cervical CancerCompletedNCT00257348Phase 2
- Phase II Iressa Versus Vinorelbine (INVITE)CompletedNCT00256711Phase 2
- Study of TPI 287 Administered Every 21 Days in Patients With Advanced MalignanciesCompletedNCT00256191Phase 1
- Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00255762Phase 2
- Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate CancerCompletedNCT00255606Phase 3
- Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00254891Phase 3
- Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following SurgeryCompletedNCT00254384Phase 1
- Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerCompletedNCT00253591Phase 2/3
- Lenalidomide and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00253344Phase 1
- RAD001 Plus Docetaxel in Patients With Metastatic Breast CancerTerminatedNCT00253318Phase 1
- A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung CancerCompletedNCT00251446Phase 2
- GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast CancerTerminatedNCT00251433Phase 1
- Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor MalignanciesCompletedNCT00251407Phase 1
- Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast CancerTerminatedNCT00251095Phase 3
- Combination Paclitaxel, Carboplatin and TemozolomideCompletedNCT00249964Phase 1
- Taxoprexin Treatment for Advanced Skin MelanomaCompletedNCT00249262Phase 2
- Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone MarrowCompletedNCT00248703Phase 2
- ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast CancerCompletedNCT00247481Phase 2
- Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian CancerCompletedNCT00246688Phase 2
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal RhabdomyosarcomaStatus unknownNCT00245141Phase 2
- Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal RhabdomyosarcomaStatus unknownNCT00245089Phase 2
- Taxoprexin® Treatment for Advanced Eye MelanomaCompletedNCT00244816Phase 2
- Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.Status unknownNCT00244127Phase 2
- Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyTerminatedNCT00243204Phase 3
- Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or HypopharynxCompletedNCT00243113Phase 2
- Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate CancerCompletedNCT00242918Phase 2
- ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck CancerCompletedNCT00242762Phase 2
- Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By SurgeryCompletedNCT00238407Phase 2
- Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic CancerCompletedNCT00238199Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal CancerCompletedNCT00238147Phase 1
- Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.CompletedNCT00235079Phase 4
- Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung CancerTerminatedNCT00232206Phase 2
- Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) CancersCompletedNCT00231855Phase 2
- High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF IICompletedNCT00231582Phase 2
- Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00227708Phase 2
- Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue LeiomyosarcomaCompletedNCT00227669Phase 2
- Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian CarcinomaCompletedNCT00226915Phase 3
- Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic CancerWithdrawnNCT00226746Phase 2
- Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant MelanomaStatus unknownNCT00226473Phase 4
- Combination Chemotherapy +/- Radiation in High Risk Hodgkin's DiseaseTerminatedNCT00225173Phase 2
- Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast CarcinomaTerminatedNCT00225056Phase 2